LOGO
LOGO

Gilead Sciences Inc. Q4 Profit Decreases, misses estimates

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Gilead Sciences Inc. (GILD) released earnings for fourth quarter that decreased from the same period last year and missed the Street estimates.

The company's earnings came in at $1.43 billion, or $1.14 per share. This compares with $1.64 billion, or $1.30 per share, in last year's fourth quarter.

Excluding items, Gilead Sciences Inc. reported adjusted earnings of $2.16 billion or $1.72 per share for the period.

Analysts on average had expected the company to earn $1.76 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter fell 3.7% to $7.12 billion from $7.39 billion last year.

Gilead Sciences Inc. earnings at a glance (GAAP) :

-Earnings (Q4): $1.43 Bln. vs. $1.64 Bln. last year.
-EPS (Q4): $1.14 vs. $1.30 last year.
-Analyst Estimates: $1.76
-Revenue (Q4): $7.12 Bln vs. $7.39 Bln last year.

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19